Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22854661 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older
Condition: H1N1 Subtype Influenza A
Intervention: Biological: (GSK2340274A) Arepanrix™

Indicates status has not been verified in more than two years